back to top

Home

Home

COMPANY

Cingulate® (CTx®) is a biopharmaceutical company focused on the development of new product candidates for the treatment of central nervous system and neurobiological disorders.

Image of people

PIPELINE

Cingulate® currently has two product candidates in pre-clinical development for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

Image of two people eating

ADHD

Attention Deficit/Hyperactivity Disorder (ADHD) is a chronic neurobiological and developmental disorder that affects millions of children and often continues into adulthood.

 

The Precision Timed Release™ Platform

 

The Precision Timed Release™ Platform is a triad of proprietary, sophisticated elements

  • Proprietary Erosion Barrier Layer (EBL)
  • Specialized compression technology
  • Semi-continuous manufacturing & real-time release
 
Explore
 
 
Precision Timed Release Tablet Diagram

Computed Tomography Scan (CT scan) of CTx-1301 tablet